Loading...

INDRANIB Indrayani Biotech Ltd Other Special Situation Announcement

ndry

NDRN

Indrayani Biotech Ltd

(INDRANIB)

2025 Announcement

Board meeting outcome

Board meeting for results

Board meeting postponement

Director Resignation

Share Transfer Update

Compliance Certificate

AGM Resolutions Passed

New Secretary Appointment

Rights Issue Approval

Shareholder Communication

AGM Notice Published

AGM Announcement

Management Change

Management Change

Management Change

Management Change

Revised Financial Results

Financial Results Published

Compliance Certificate

Financial Results Publication

Board Meeting Outcome

Management Change

Board Meeting Adjourned

Board Meeting Adjourned

Annual Compliance Report

Rights Issue Approval

Compliance Certificate

Fundraising Update

New CFO Appointment

CFO Resignation

Board Meeting Outcome

Financial Results Clarifica...

Financial Results Publication

Company Presentation

Board Meeting Notice

Board Meeting Postponed

Compliance Certificate

Financial Results Published

Rights Issue Approved

Price Movement Clarification

Compliance Certificate

Financial Results Press

Notice of AGM and E-Voting

Announcement of Board Meeti...

Certificate Submission

Financial Update

Financial Publication

Compliance Report Submission

Acquisition of Stake in Dil...

Certificate Received

Compliance Certificate Subm...

Certificate Submission

Resignation Announcement

Special resolutions approved

Financial Results Announcement

Appointment Of V.Santhanakr...

Clarification on Price Move...

Certificate under Regulatio...

Board Meeting Outcome

Appointment of Company Secr...

Resignation of Company Secr...

Amendment Approval & Appoin...

IPO filing by subsidiary

SEBI Compliance Certificate

Re-appointment of Directors...

Disinvestment of IHHC

Acquisition Announcement

Financial Statements

Asset Acquisitions

Financial Statements Public...

Management confirmation

External Links:

Data:

Indrayani Biotech Ltd's wholly-owned subsidiary, IBL Investment Limited, has received SEBI approval for a Category II Alternate Investment Fund effective from September 15, 2025.

AI Assistant

Indrayani Biotech Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.